Online: | |
Visits: | |
Stories: |
Story Views | |
Now: | |
Last Hour: | |
Last 24 Hours: | |
Total: |
Vatic Note: Why do I spend so much time on cancer and various treatments? Because I found out and put up on the blog, years ago, that chemtrails contain cancer cells and I believe they are a part of the soft kill program to reduce the worlds population, while also moving toward tighter control of those who survive and will serve as slaves and serfs for the elite.
More people are dying younger from Cancer and that means families are losing fathers, mothers and children to this disease. Its time we find ways to overcome it. I watched my mother die from it and it broke my heart. Its not just the death but the suffering which is part of the sacrifice to satan.
The Georgia Guidestones were put up in 1974 by the Luciferian society, so the connection is clear. They are required to always tell us in advance what they intend to do to us and the Guidestones were one of those ways.
Movies and TV programming, like the Simpsons, are another way they tell us. Then if we do nothing about it, they are not at fault. So read this as an alternative to chemotherapy. As you know, I am a natural remedy person, so that is where I would normally direct you, but I believe its important you have all the facts and decide for yourself.
What is Genetically Targeted Fractionated Chemotherapy? – Does it actually spread Cancer?
http://envita.com/cancer/what-is-genetically-targeted-fractionated-chemotherapy?utm_source=OB&utm_medium=GTF+Chemo&utm_term=Chemotherapy+linked+to+Cancer+Spread+&utm_content=article+&utm_campaign=GTF+Chemo
In this article, we'll explore the new science and important application of translational cancer genomics and epigenetics in a unique integrative medical setting and how this information can help patients and clinicians alike attain much more personalized cancer treatment plan.
Genetic Research Sparks Hope of Cancer BreakthroughWe hope this information will provide you with a clearer understanding of this complex disease and give you some helpful solutions to helping you or a loved one. We don't claim to have all the answers, but we are sharing our over a decade of cancer treatment as well as our understanding and unique solutions to the current challenges with chemotherapy.
The Scientific Consensus on a Genetically Targeted Future
Why Are 70% Of Cancer Patients Unresponsive to Chemotherapy Treatments?
At the world famous Cell Symposia: Hallmarks of Cancer, that took place in San Francisco in 2012, numerous presenters made it very clear that the way forward in curing cancer is understanding each person's cancer cell biology via genetic and molecular profiling.[1] This symposium included talking points from Robert Kruger, Deputy Editor at Cell, Lynda Chin of MD Anderson Cancer Centre, Sandra Horning of Genentech, Richard Gilbertson of St. Jude Children's Research Hospital and Bob Weinberg of Whitehead Institute for Biomedical Research.
The Science Behind Our Solutions
Improvement in cancer survival has come mainly from early detection and surgical removal in early stages of certain cancers (breast, prostate and colon), however whenever spread is involved with advanced metastatic cancer, the old or rather current chemotherapy practices are not much more effective at aiming for long-term remissions, dare we say cure. The War on Cancer has had several of the same challenges for decades, including difficulty:
Additional Background on Cancer Growth and ChemotherapyHaving translational cancer genomics, biomarkers and molecular profiles is like having the blueprints to better treat the patient and provide a much better way forward. Chemotherapy treatments, both presently and in the past, have focused solely on the location of the tumor, tissue pathology and staging, but the future of research and our group included focuses on the genetic typing and molecular profiling of the tumor, giving the patient a much needed edge.
One of the main reasons for this heterogeneity of cancer cells is the ever-important epigenetic environment around the cancer cells that may contribute to mutation and uncontrolled growth. In a nutshell, cancer cell biology illustrates that successful cancer treatment is like trying to hit multiple moving targets at once. However, there is hope; our experience has shown that a multi-step approach including GTFC may provide helpful options to patients.
Most people have a general understanding of chemotherapy, but for the purposes of this article, let's review. Cancer is when your body's cells begin uncontrolled, unchecked growth that is malignant; it is caused by a mix of environmental toxins, infectious agents leading to chronic inflammation and genetic mutations. In fact, these mutations can continue throughout the evolution of the cancer. Chemotherapy is a treatment for cancer using cytotoxic chemicals (poisonous to living cells) and other drugs.
Typically, the problems with high-dose and protocol-driven chemotherapy treatments are the many adverse side effects, which depends on the type of medication used. These side effects become worse when combination of drugs are given to help reduce resistance from cancer cells, but it can often times increase toxicity in the patient. This explains why some chemo drugs work for some, but don't work for others. In fact, it has been proven that chemotherapy increases survival only slightly over 2% in late-stage cancers for five-year survival.[2]
In the end, there is no way of knowing where these chemotherapy agents are going to work at all or if the cancer is going to come back even worse. Some of the most common side effects include:
Most cancer centers and hospitals have adopted a “let the patient die in dignity” attitude, but our group is passionate about helping patients live with dignity. That's why we've been spending over a decade developing what we call the most comprehensive approach. In that approach, we can utilize GTFC (genetically targeted fractionated chemotherapy).
Genetically Targeted Fractionated Chemotherapy
That's where Genetically Targeted Fractionated Chemotherapy comes in. In short, GTFC is an advanced form of chemotherapy that applies molecular profiles, genetic typing and targeted treatment, providing patients with much needed alternatives. This method allows us to use multiple drugs in lower dosages to help reduce resistance, enhance targeting and improve overall treatment.
GTFC sessions are also shorter and use lower-dosages. Therefore, GTFC is much less taxing on your body. When combined with targeted immunotherapy and nutritional therapy, patients that utilize GTFC often claim they have more energy and feel healthier compared to the standard methods used.
It's fair to say that this technology is still in its infancy and getting better all the time, but if you ask patients like Nicole Sanko, she'll tell you it was a lifesaver. It was this approach coupled with a complete treatment protocol that brought her into remission in late-stage endometrial adenocarcinoma. It's worth noting some patients were hospice-bound, being told to go home and die, but have now enjoyed a longer and better quality of life.
Other Protocols Combined with GTFC
What GTFC can do for Patients
We have encountered several colleagues that are excited by our work but also skeptics that feel that the data is insufficient. However, the majority of our patients are outperforming in multiple categories, most importantly increasing the quality and length of life.
The bottom line is, when appropriate and combined with other programs, GTFC helped patients have access to powerful personalized cancer treatment options. The best part about these treatments is they are helpful for most, if not all cancers. If you have questions about your specific cancer, want to learn more about this revolutionary new chemotherapy protocol and related treatments or need an answer to any of your questions, please contact us today.